A patient-level meta-analysis of four RCTs [48] evaluated the post-surgical adjuvant treatment effects between aromatase inhibitors and tamoxifen for postmenopausal women with ER+ early-stage breast cancer. Here, CYP19A1 is linked to breast carcinoma.